YD Bio Ltd
YDES- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0002011674
In the last 90 days, YD Bio Ltd insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $639.6K in total; no superinvestor holds it.
Other share classesYDESW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by YD Bio Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 3 filings
- 1 insider, $128.5K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$128.5K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for YD Bio Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Shen Ethan PhD | CEO | 11,258,331 | Sep 16, 2026 | 3 |
| Lu Shao-Ta | Director | 7,830 | Jul 1, 2026 | 2 |
| Chang Kochi | Director | 7,830 | Jul 1, 2026 | 2 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 (view filing)4:01 PM ET | Sep 14 | 2 days | Shen Ethan PhDCEO | PPurchase | +12.7K | $3.85 | +$48.9K | +0.1%11.3M after | |
| Sep 10, 2026 (view filing)4:01 PM ET | Sep 9 | 1 day | Shen Ethan PhDCEO | PPurchase | +3.10K | $3.93 | +$12.2K | 0.0%11.2M after | |
| Sep 8, 2026 (view filing)4:00 PM ET | Sep 4 | 4 days | Shen Ethan PhDCEO | PPurchase | +18.4K | $3.67 | +$67.4K | +0.2%11.2M after |